Almac Launches New STEMS System to Transform Temperature Controlled
Shipment Monitoring in Clinical Trials
Almac Clinical Services marked the start of 2010 with the official launch of a new state-of-the-art
web-based, Shipping Temperature Electronic Monitoring System - stems. Unique to the
pharmaceutical and biotech industries, this latest addition to the Almac services portfolio is set to
revolutionise the management of temperature controlled shipments within the clinical trial
(PRWEB) February 17, 2010 -- Novel technology saves time and reduces costs in clinical studies.
Temperature excursions can inhibit the clinical supply chain, resulting in crucial investigational products being
delayed or quarantined and not made available for immediate use at the study site. Excursions can occur at any
point in a global supply chain and often arise as a result of multiple uncontrollable factors.
Upon download, Almac's Shipping Temperature Electronic Monitoring System - stems, equips clinical supply
professionals with immediate visibility over all crucial shipment temperature reports. This enables users to make
instant decisions 24/7 on their clinical supplies without the need for monitor returns or faxing of results.
Stems reduces any quarantine time for clinical supplies at study sites, saving both time and money for a global
stems is the latest addition to the Almac services portfolio for temperature controlled clinical supplies. Alongside
the Group's Specialist Temperature Controlled Team, and customised shipping unit systems, this new technology
delivers the following key features:
• 100% shipping temperature reports - allowing root cause analysis for process improvements
saving time & financial resources in large global trials
• Instant reporting enabling near zero quarantine time - improved inventory management whilst saving time
and reducing costs
• Fully-validated system - compliant with 21 CFR Part 11 requirements
• No return shipments